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Abstract
Background:  The overlap between Depression and Anxiety has led some researchers to
conclude that they are manifestations of a broad, non-specific neurotic disorder. However, others
believe that they can be distinguished despite sharing symptoms of general distress. The Tripartite
Model of Affect proposes an anxiety-specific, a depression-specific and a shared symptoms factor.
Watson and Clark developed the Mood and Anxiety Symptom Questionnaire (MASQ) to
specifically measure these Tripartite constructs. Early research showed that the MASQ
distinguished between dimensions of Depression and Anxiety in non-clinical samples. However,
two recent studies have cautioned that the MASQ may show limited validity in clinical populations.
The present study investigated the clinical utility of the MASQ in a clinical sample of adolescents
and young adults.
Methods: A total of 204 Young people consecutively referred to a specialist public mental health
service in Melbourne, Australia were approached and 150 consented to participate. From this, 136
participants completed both a diagnostic interview and the MASQ.
Results: The majority of the sample rated for an Axis-I disorder, with Mood and Anxiety disorders
most prevalent. The disorder-specific scales of the MASQ significantly discriminated Anxiety
(61.0%) and Mood Disorders (72.8%), however, the predictive accuracy for presence of Anxiety
Disorders was very low (29.8%). From ROC analyses, a proposed cut-off of 76 was proposed for
the depression scale to indicate 'caseness' for Mood Disorders. The resulting sensitivity/specificity
was superior to that of the CES-D.
Conclusion: It was concluded that the depression-specific scale of the MASQ showed good
clinical utility, but that the anxiety-specific scale showed poor discriminant validity.
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Background
The Tripartite model
Mood and anxiety disorders are often comorbid [1,2].
This finding is not surprising given the symptom overlap
between these two syndromes [3]. A Tripartite model of
Affect has been proposed to account for this overlap and
to identify the unique components of anxiety and depres-
sion [4]. Under this model, Negative Affect (NA), a mixed
anxiety-depression factor, explains the comorbidity
between these syndromes. Positive Affect (PA) is the
depression-specific factor and Physiological Hyperarousal
(PH) is unique to anxiety.
There is some evidence for the Tripartite model for its abil-
ity to distinguish between depression and anxiety [5-9].
However, some findings have suggested the need to mod-
ify the original model [10]. For example, PH may only be
related to Panic Disorder and, to a lesser extent, General-
ised Anxiety Disorder.
Much of the research into the validity of the tripartite
model has been conducted with measures that were not
specifically designed to measure the tripartite constructs
(e.g. BDI, BAI). Specific measures may be necessary to
explore the utility of the model [11].
The Mood and Anxiety Symptom Questionnaire
The Mood and Anxiety Symptom Questionnaire (MASQ)
was designed to be a specific measure of the Tripartite
model of Affect [12,13]. Three general distress scales
measure the postulated shared factor, NA. A depression-
(Anhedonic Depression, AD) and anxiety-specific (Anx-
ious Arousal, AA) scale measures PA and PH respectively.
Watson et al. reported good discriminant and convergent
validity for the MASQ across five samples comprising col-
lege students, adults sampled from the community and
patients presenting to a pain clinic. Factorial validity for
the MASQ has been established in non-clinical samples,
with three factors consistently found to best represent the
data [7,13,14]. However, a recent study employed con-
firmatory factor analysis with depressed and anxious
patients and reported that the structure of the tripartite
model was not confirmed in this clinical sample [15].
Additionally, two recent studies have questioned the dis-
criminant validity of the MASQ in clinical samples
[16,17]. Discriminant validity reflects the extent to which
an instrument measures the construct it is purported to
measure, without inadvertently measuring other
domains/constructs. Buckby et al. reported that depressed
participants rated higher than non-depressed participants
on all MASQ scales, including the anxiety-specific AA. Fur-
thermore, they reported that participants with anxiety dis-
orders did not score higher than participants without a
current disorder on any scale. Boschen and Oei [16]
reported that although the MASQ scales significantly dis-
criminated between anxiety and depression, there was lit-
tle clinical utility in these findings as the maximum
discrimination was only 70%. Both studies cautioned
future researchers to be mindful of the potential weakness
of the MASQ's validity in clinical samples and indicated
that further research, including replication, was necessary
to better understand this issue.
Rationale and hypotheses
Boschen & Oei [16] used a clinical sample of adults with
Mood and Anxiety disorders. A recent review has criticised
researchers for unduly focusing on psychometric charac-
teristics and neglecting sensitivity [18]. Using similar anal-
yses to Boschen & Oei, the present study therefore
attempted to replicate their findings in a clinical sample of
adolescents and young adults in order to determine how
generalisable those findings were. People in the early
stages of mental disorders may be especially receptive to
treatment and may require more benign interventions
than chronic populations [19]. It is therefore important to
be able to validly recognise psychological distress in peo-
ple at-risk of mental disorder. Should the MASQ be deter-
mined to validly detect depression and anxiety, it could
prove to be a useful tool that is easily administered by pro-
fessions including GPs and triage workers. It was hypoth-
esised that the MASQ would show marginal to weak
criterion validity in the present sample. A secondary aim
was to compare the MASQ depression scale, AD, with the
Center for Epidemiologic Studies Depression Scale (CES-
D) [20]. The CES-D is a widely-used measure of depressive
symptomatology that has been validated in both adult
and adolescent samples [20,21]. However, some research-
ers have questioned its specificity to depression. For exam-
ple, the CES-D has high reported correlations with anxiety
measures and contains items that are not specific to
depression. The present study sought to determine
whether the MASQ offered an improvement to this earlier
measure.
Methods
Ethics approval for this study was given by the local ethics
board, the Melbourne Health research and ethics commit-
tee.
Participants
Participants were 150 people aged 15–24 years consecu-
tively referred to ORYGEN Youth Health (OYH), a special-
ist youth public mental health service in Melbourne,
Australia. Sources of referral included family, GPs, hospi-
tals and school counsellors.
Procedures
Between April and September, 2003, all young people
who were referred to OYH with non-psychotic disorders
were approached by trained research interviewers. Con-BMC Psychiatry 2007, 7:50 http://www.biomedcentral.com/1471-244X/7/50
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senting participants completed the MASQ and a diagnos-
tic interview. Inter-rater assessments were conducted in
approximately 15% of the cases to ensure agreement
between interviewers. Kappa values for mood (0.89) and
anxiety diagnoses (0.80) were high.
The sample, setting and methodology have been
described in greater detail elsewhere [22,23].
Measures
Mood and Anxiety Symptom Questionnaire (MASQ)
The MASQ is a 77-item self-report questionnaire that
assesses depressive, anxious and mixed symptomatology
[12,13]. Three scales measure General Distress: depressive
symptoms (12 items), anxious symptoms (11 items) and
mixed symptoms (15 items). There is also an anxiety-spe-
cific (Anxious Arousal, 17 items) and depression-specific
scale (Anhedonic Depression, 22 items). Higher scores
reflect greater levels of symptomatology. The reported
internal consistency for each scale is excellent with coeffi-
cient alphas ranging from 0.78 to 0.92.
Structured Clinical Interview for DSM-IV (SCID-IV)
The SCID-IV was administered to assess for Axis-I disor-
ders and is a semi-structured interview [24]. All assess-
ments were conducted by trained research interviewers.
Cases were presented at weekly clinical meetings with
experienced doctoral-level clinical psychologists confirm-
ing diagnoses.
Centre for Epidemiologic Studies- Depression Scale (CES-D)
The CES-D is a 20-item self-report questionnaire that
assesses depressive symptomatology [20]. The psycho-
metric properties of the CES-D have been established in
both adult and adolescent samples [20,21]. Higher CES-D
scores reflect greater levels of symptomatology.
Results
Characteristics of the sample
Two hundred and four people met the study criteria dur-
ing the recruiting phase. Of the 150 consenting partici-
pants 14 did not return valid questionnaires, leaving a
sample of 136 with useable data. There was no significant
demographic differences between those with, and without
missing data. A small proportion of participants (< 10%)
had several, random missing variables replaced with the
Expectation Maximisation method [25].
The mean age of participants was 18.11 years (SD = 2.61)
and the sample was comprised of 61% females (N = 83).
There was no significant gender difference in MASQ
scores. There was a significant difference between adoles-
cents (age 15–17) and young adults (age 18–24) on all
MASQ scales except AA with older participants scoring
higher.
The majority of the sample (80.1%, N = 109) rated for a
current Axis-I disorder. Mood and Anxiety disorders were
most common. The sample was split according to diag-
nostic status: Mood Disorder only (no comorbid anxiety,
N = 29, 21.3%); Anxiety Disorder only (no comorbid
mood, n = 22, 16.2%); Comorbid Anxiety-Mood (n = 35,
25.7%); and no Anxiety or Depression (n = 50, 36.8%).
The most common Anxiety disorders were specific phobia
(16.9%), social phobia (15.4%) and panic disorder
(11.0%). Post traumatic stress (8.1%), generalised anxiety
(5.1%) and obsessive compulsive (6.6%) disorders were
less frequent. Nearly half (46%) of the no anxiety-mood
group rated for another Axis-I diagnosis (including sub-
stance abuse/dependence and eating disorders). Preva-
lence of other disorders has been described elsewhere [2].
Descriptive statistics and correlational analyses
Means and standard deviations are presented in Table 1.
Inter-correlations between all MASQ scales were uni-
formly high and statistically significant with the lowest
correlation between the disorder-specific scales AA and
AD (r = 0.59, see Table 2). Inter-correlations between
AA:AD were inspected across the diagnostic groups. This
correlation was high in all groups rating for either a Mood
or Anxiety Disorder with the highest correlation in Anxi-
ety only (r = 0.62), followed by Comorbid (r = 0.60) and
Table 1: Descriptive statistics for MASQ and CES-D scores
Total sample (N = 136) Mood only (N = 29) Anxiety only (N = 22) Comorbid (N = 35) No Anxiety/Depression (N = 50)
Mean (SD)
GD: M 44.20 (14.40) 49.04 (14.98) 37.55 (13.45) 53.20 (11.37) 38.01 (12.06)
GD: A 25.17 (9.40) 28.80 (9.27) 21.82 (7.73) 31.39 (9.46) 20.17 (6.40)
GD: D 33.31 (12.86) 37.63 (12.78) 27.72 (11.88) 42.77 (10.78) 26.63 (9.31)
AA 34.08 (13.38) 38.11 (16.38) 30.63 (11.18) 40.94 (13.26) 28.46 (9.14)
AD 75.81 (17.43) 82.82 (8.31) 67.18 (17.13) 87.80 (12.24) 67.13 (14.05)
CES-D 26.71 (9.75) 30.69 (8.31) 22.05 (9.23) 32.66 (9.78) 22.20 (7.35)
Note: GD: M = General Distress: Mixed; GD: A = General Distress: Anxious; GD: D = General Distress: Depressive; AA = Anxious Arousal; AD = 
Anhedonic Depression.BMC Psychiatry 2007, 7:50 http://www.biomedcentral.com/1471-244X/7/50
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Mood only (r = 0.46) (p < .001 for all). In contrast, AA:AD
was only moderately correlated in the no Anxiety/Mood
group (r = 0.35, p = 0.01). When examining those partici-
pants without any current diagnoses (N = 27), AA:AD
were uncorrelated (r = 0.18, p = 0.36). This finding indi-
cated a differential relationship for the correlation
between those with (r = 0.59, p < .001, N = 109) and those
without an Axis-I disorder. Therefore, an independent
samples t-test of the correlational coefficients was con-
ducted [26], showing a significantly higher correlation in
a composite diagnosis group that included participants
with any current disorder (z = 4.04, p < .001).
Logistic regression analyses- Predicting mood disorder
To replicate earlier findings [16] logistic regression analy-
ses were run with diagnostic status as the dependent vari-
able. In the first analysis, a dichotomous outcome
variable was created reflecting presence (n = 64, 47.1%)
versus absence (n = 72) of a Mood Disorder. The depres-
sion-specific scale AD was included in the first block of
covariates, the three GD scales in the second block and AA
in the third block.
AD significantly predicted mood disorder (χ2 (1) = 44.06,
p < .001). The addition of the GD scales in the second
block did not significantly increase the prediction of
mood disorder (p = 0.09), nor did inclusion of AA at the
third step (p = 0.78). The overall predictive accuracy of AD
for a mood disorder was 72.8% (71.9% for presence and
73.6% for absence of a mood disorder).
Logistic regression analyses- Predicting anxiety disorder
In the second analysis, presence (n = 57, 41.9%) versus
absence (n = 79) of an anxiety disorder was the dependent
variable. The anxiety-specific scale AA was included in the
first step, the GD scales in the second, and AD in the third
step.
AA significantly predicted anxiety disorder (χ2 (1) = 4.58,
p = 0.03). The GD scales did not increase the prediction (p
= 0.15), nor did AD in the final step (p = 0.79). The overall
predictive accuracy of AA for an anxiety disorder was
61.0% (29.8% for presence and 83.5% for absence).
ROC analyses
The ROC curve allows researchers to graphically deter-
mine a test's sensitivity and specificity [27]. The area
under the curve of a ROC plot provides a score that ranges
from 1 (test is always correct) to 0 (test is never correct). A
score of 0.5 indicates that the result is no better than
chance. When comparing different tests, the one with the
larger area under the curve is determined to be the better
diagnostic tool.
In the first analysis, the dichotomous Mood disorder var-
iable was entered as the state variable and the disorder-
specific scales AA and AD and the CES-D were entered as
the test variables. The ROC plot for AD contained 81.8%
under the curve (SE = 0.04, 95% C.I. = 0.75, 0.89), AA
contained 72.3% (SE = 0.04, 95% C.I. = 0.64, 0.81) and
CES-D contained 78.7% (SE = 0.04, 95% C.I. = 0.71,
0.86).
In the second analysis, the dichotomous anxiety variable
was input as the state variable and the disorder-specific
scales as the test variables. The ROC plot for AA contained
61.7% under the curve (SE = 0.05, 95% C.I. = 0.52, 0.72),
AD contained 62.0% (SE = 0.05, 95% C.I. = 0.53, 0.72)
and CES-D contained 58.3% (SE = 0.05, 95% C.I. = 0.48,
0.68).
The sensitivity and specificity of AD was further inspected
to identify a potential cut-off to indicate 'caseness' for
depression. By visually inspecting the ROC for the largest
area under the curve and by manually comparing various
true positive and true negative rates, it was determined
that an AD cut-off of 76 best reflected caseness (sensitivity
= 85%, specificity = 65%). These figures were then com-
pared to CES-D (cut-off = 24). AD is equivalent to, if not
better than, the CES-D (sensitivity = 84%, specificity =
61%) in discriminating Mood Disorders when utilising
the proposed cut-off of 76. Further analyses with AA were
not run as this scale demonstrated poor discriminant
validity (see above) (Figures 1 and 2).
Discussion
The current study investigated the ability of the MASQ's
AD and AA scales to distinguish between Anxiety and
Mood Disorders. We sought to assess the discriminant
validity of the MASQ in a clinical sample of adolescents
and young adults (mean age = 18.11 years). We attempted
to replicate and extend statistical methods used by
Boschen & Oei [16], who had a sample of 470 adult
patients with Mood and Anxiety Disorders (mean age =
34.30 years). Present results largely supported the earlier
findings.
Table 2: Inter-correlations between MASQ scales and CES-D
GD: M GD: A GD: D AA AD CES-D
GD: M [0.92]
GD: A 0.86* [0.88]
GD: D 0.86* 0.83* [0.93]
AA 0.74* 0.80* 0.69* [0.91]
AD 0.79* 0.75* 0.82* 0.59* [0.93]
CES-D 0.82* 0.79* 0.83* 0.65* 0.72* [0.93]
Note: Figures on the diagonal in parentheses denote Cronbach's alpha, 
a measure of internal consistency.
* denotes p < .001.BMC Psychiatry 2007, 7:50 http://www.biomedcentral.com/1471-244X/7/50
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First, the disorder-specific scales AA and AD were signifi-
cant predictors of the target dependent variable anxiety
and depression respectively. AD was superior to AA in pre-
dicting its target syndrome. AD accurately predicted Mood
disorders (72.8%). However, AA weakly predicted Anxiety
disorders (61% of overall cases). Interestingly, AA pre-
dicted the absence of anxiety well (83.5%) but very poorly
predicted the presence of these disorders (29.8%). These
findings add further support to earlier analyses with the
same sample [17]. In that study we reported that
depressed participants scored highly on all scales but that
those rating for Anxiety Disorders were not distinguished
from those without an Axis-I disorder. The present find-
ings are comparable to those obtained by Boschen & Oei,
who reported depression being predicted 66.4% and anx-
iety 61.1% of the time. There are some notable differences
between the present results and those of Boschen & Oei.
First, the slightly higher prediction of depression in the
present study is related to a more accurate prediction of
the presence of depressive disorder by AD in our sample.
In Boschen & Oei's study, the presence of depression was
only predicted 42.3% of the time (versus 71.9% in the
current study). Second, though the overall prediction of
Anxiety is identical across studies, very low prediction of
Anxiety Disorder was reported in the current study but
was high (81.5%) in Boschen & Oei's study. Third, the
three MASQ general distress scales did not significantly
increase the prediction above that explained by the disor-
der-specific scales in this replication. They were significant
predictors in the original study.
The ROC analyses, were also supportive of the earlier find-
ings reported by Boschen & Oei [16], particularly for the
weak utility of the AA scale. Results were more positive for
AD. When implementing the proposed cut-off for the AD
scale (76 or greater), 85% of depressed participants were
correctly identified. The low true negative rate (non-
depressed participants incorrectly identified, 65%) is
comparable to that reported elsewhere with adolescent
samples [28]. As we have argued elsewhere [17], anxiety
and depressive syndromes may not yet be clearly distin-
guished in populations similar to the present sample,
which may account for the MASQ's failure to distinguish
between them.
Results from the present correlational analyses further
illustrate the psychometric limitations of the MASQ in the
present sample. Though specifically designed to distin-
guish distinct depressive, anxious and general distress syn-
dromes, all five MASQ scales were highly inter-correlated.
The AA:AD correlation was lowest, but still highly and sig-
nificantly correlated in all participants rating for a current
Axis-I disorder (r = 0.59). This correlation is particularly
high for scales that are supposedly separate constructs and
provides further evidence for this measure's limitations in
clinical samples. A closer inspection of this correlation in
those participants without a current disorder revealed
these disorder-specific scales were not correlated (r =
0.18). These results provide further evidence that the
MASQ, and hence the tripartite model, will require signif-
icant revision for use with clinical samples. The results
presented in the current study suggest that that anxiety-
specific scale, AA, may be most in need of revision.
The present results provide further support for the notion
that caution be employed by researchers when planning
the use of the MASQ in clinical samples. All scales are
highly correlated, limiting the utility of the scale for dis-
ROC analyses for Mood diagnosis by AA, AD and CES-D Figure 2
ROC analyses for Mood diagnosis by AA, AD and CES-D.
ROC analyses for Anxiety diagnosis by AA, AD and CES-D Figure 1
ROC analyses for Anxiety diagnosis by AA, AD and CES-D.BMC Psychiatry 2007, 7:50 http://www.biomedcentral.com/1471-244X/7/50
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tinguishing between Anxiety and Mood Disorders. Results
from both logistic regression and ROC analyses showed
that the depression-specific scale, AD, had good discrimi-
nant validity in detecting the presence of Mood Disorders
and also demonstrated clinically useful sensitivity and
specificity. The anxiety-specific scale, AA, however,
showed poor clinical utility in the present sample. This
may be because the anxiety construct of the tripartite
model, PH, has been found to have heterogeneous rela-
tionship with Anxiety Disorders. Only Panic Disorder
and, to a lesser extent, Generalised Anxiety Disorder have
been established to relate to PH [10]. Obsessive Compul-
sive Disorder and Social Phobia may be unrelated. Very
few participants in the present sample rated for GAD or
Panic Disorder (11.0 and 5.1% respectively), therefore it
is not surprising that the AA scale did not demonstrate
clinical utility. Further studies are necessary to elucidate
this issue to better determine the settings under which the
MASQ is most valid. In support of the current results, a
Dutch translation of the MASQ found only limited
uniqueness of the anxious-specific scale (compared to
Negative Affect) [29]. It may be that future revisions of the
AA scale will require the addition of items that are repre-
sentative of the spectrum of anxiety disorders. The inclu-
sion of items that relate to phobic avoidance and/or
worrying may enhance the clinical utility of this scale. At
present, AA may be considered to assess primarily panic
symptoms. Replication of current methods would also be
beneficial in similar samples to establish the generalisa-
bility of the present findings.
Though Boschen & Oei [16] concluded that both MASQ
specific scales demonstrated weak clinical utility, we argue
that the predictive utility of the AD scale (73%) may be
high enough for clinical and research use. Though the
MASQ was not designed for this purpose, the AD scale
may be superior to the widely-used CES-D in determining
clinical 'caseness' for Mood Disorders. A brief (22 item),
cheap self-report screening tool that accurately discrimi-
nates three out of four people who may warrant specialist
clinical services may be well-received by mental health
triage workers. Though the present sample is not large,
this is the first study that the authors are aware of that has
attempted to define a clinical cut-off for a MASQ scale.
Present results indicate that AD is slightly superior to the
CES-D in the current sample.
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